Cite
HARVARD Citation
Minami, H. et al. (2019). Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro. Journal of thrombosis and haemostasis. pp. 126-137. [Online].